Pfizer and biontech receive first u.s. authorization for emergency use of covid-19 vaccine in adolescents

New york and mainz, germany, may 11, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) announced today that the u.s. food and drug administration (fda) has expanded the emergency use authorization (eua) for their covid-19 vaccine to include individuals 12 to 15 years of age. this is the first covid-19 vaccine authorized in the u.s. for use in this age group.
BNTX Ratings Summary
BNTX Quant Ranking